PTK2 and glioblastoma: Its overexpression can inhibit metastasis and invasion of GBM cells by directly repressing FAK, a mediator of cell‐extracellular matrix signaling, as well as by reducing the expression of MMP2 and MMP9, thereby decreasing the ability of GBM cells to move through extracellular matrix 75.